Search Results - "BOTSIOS, C"

Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate by Ostuni, P, Botsios, C, Punzi, L, Sfriso, P, Todesco, S

“…DISCUSSION Hepatitis B reactivation is a well known adverse event in patients with chronic HBV infection receiving cytotoxic or immunosuppressive treatment. 3…”
Get full text

Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept by Fiocco, U, Ferro, F, Vezzù, M, Cozzi, L, Checchetto, C, Sfriso, P, Botsios, C, Ciprian, L, Armellin, G, Nardacchione, R, Piccoli, A, Todesco, S, Rubaltelli, L

“…Objective: To determine the effect of tumour necrosis factor α (TNFα) blockade with etanercept in refractory knee joint synovitis (KJS) in rheumatoid and…”
Get full text

Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases by Botsios, C., Sfriso, P., Ostuni, P. A., Todesco, S., Punzi, L.

Get full text

Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra by Botsios, C., Sfriso, P., Punzi, L., Todesco, S.

Get full text

Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis by Fiocco, U., Sfriso, P., Oliviero, F., Sovran, F., Scagliori, E., Pagnin, E., Vezzù, M., Cozzi, L., Botsios, C., Nardacchione, R., Di Maggio, A., Rubaltelli, L., Giacometti, C., Calabrese, F., Todesco, S.

“…Pigmented villonodular synovitis (PVNS) is a rare pre-malignant disease that require aggressive treatment as surgical synovectomy, eventually followed by…”
Get full text

Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab by Hoxha, A., Ruffatti, A., Grypiotis, P., Podswiadek, M., Botsios, C., Fiocco, U., Punzi, L., Todesco, S.

“…Objective: We evaluated the induction and clinical significance of ANA, anti-dsDNA and anti-ENA during infliximab therapy in patients with Rheumatoid Arthritis…”
Get full text

Imaging in major salivary gland diseases by Botsios, C., Sfriso, P., Grava, C., Ostuni, P., Andretta, M., Tregnaghi, A., Zucchetta, P., Gambari, P. F.

“…Most of the salivary glands diseases are characterized only by a few distinct clinical patterns. Medical history and clinical examination are still considered…”
Get full text

Nasopharyngeal carcinoma and Dermatomyositis: a case report by Botsios, C., Boscolo Rizzo, P., Da Mosto, M.C., Ostuni, P., Sfriso, P., Todesco, S., Marchiori, C.

“…Nasopharyngeal carcinoma has long been reported as the predominant type of cancer associated with dermatomyositis in many several Asian countries, including…”
Get full text

TNFα blockers and infectious risk in rheumatoid arthritis by Raffeiner, B., Botsios, C., Ometto, F., Bernardi, L., Montante, A., Sfriso, P., Todesco, S., Punzi, L.

“…Patients suffering from rheumatoid arthritis have increased risk of infections when compared with general population. The risk depends directly from disease…”
Get full text

Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis by Botsios, C, Sfriso, P, Furlan, A, Ostuni, P, Biscaro, M, Fiocco, U, Todesco, S, Punzi, L

“…We evaluated both the efficacy and safety of anakinra in daily routine rheumatoid arthritis clinical practice. We studied 60 cases, including patients with…”
Get full text

Incidence and management of infusion reactions to infliximab in 186 italian patients with rheumatoid arthritis: the Padua experience by Botsios, C, Ostuni, P, Todesco, S

“…We report the incidence and treatment of infusion reactions to infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor alpha, in a large…”
Get full text

Dermatomyositis and malignancy of the pharynx in Caucasian patients: report of two observations by BOTSIOS, C, OSTUNI, P, BOSCOLO-RIZZO, P, DA MOSTO, M. C, PUNZI, Leonardo, MARCHIORI, C

“…The association between dermatomyositis and malignancy of the pharynx is rare among whites but not uncommon among Far Eastern and north African populations. We…”
Get full text

Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases by Botsios, Costantino

“…The three licensed TNFα blocking agents (etanercept, infliximab, adalimumab) and the recombinant form of human interleukin-1-receptor antagonist (anakinra)…”
Get full text

A long-term nationwide study on mortality associated to rheumatoid arthritis in Italy by Ometto, Francesca, Fedeli, Ugo, Botsios, Costantino, Punzi, Leonardo, Grande, Enrico

“…We aimed to evaluate trends of rheumatoid arthritis (RA) mortality reported as the underlying cause of death (UCD) and as multiple causes of death (MCD) in…”
Get more information

Adult Henoch-Schönlein purpura with glomerulonephritis and paroxysmal nocturnal haemoglobinuria: an uncommon association by Cozzi, F, Botsios, C, Ostuni, P, Sfriso, P, Piva, E, Marson, P, Punzi, L, Todesco, S

“…Henoch-Schönlein purpura (HSP) is considered to be a small blood vessel systemic vasculitis. Numerous microorganisms have been implicated in triggering HSP. We…”
Get full text

Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects by Botsios, C, Ostuni, P, Sfriso, P, Furlan, A, Fiocco, U, Sgarabotto, D, Todesco, S

“…Different animal studies show that several proinflammatory cytokines are essential for natural resistance to specific infections, particularly versus…”
Get full text

Adherence in rheumatoid arthritis patients assessed with a validated Italian version of the 5-item Compliance Questionnaire for Rheumatology by Ometto, Francesca, Raffeiner, Bernd, Azzolina, Danila, Botsios, Costantino, Astorri, Davide, Friso, Lara, Favero, Marta, Done, David John, Gregori, Dario, Doria, Andrea

“…The 5-item Compliance Questionnaire for Rheumatology (CQR5) proved reliability and validity in respect of identification of patients likely to be high adherers…”
Get full text

Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose by Raffeiner, Bernd, Botsios, Costantino, Ometto, Francesca, Bernardi, Livio, Stramare, Roberto, Todesco, Silvano, Sfriso, Paolo, Punzi, Leonardo

“…This prospective long-term follow-up study evaluated the effects of half-dose etanercept (25 mg weekly) on clinical remission and radiographic progression in a…”
Get full text

Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment by Kobelt, Gisela, Lekander, Ingrid, Lang, Andrea, Raffeiner, Bernd, Botsios, Costantino, Geborek, Pierre

“…To explore the cost-effectiveness of early biologic treatment, followed by dose-reduction in the case of remission, of active rheumatoid arthritis (RA),…”
Get more information

PMS36 COST OF THERAPY OF TUMOR NECROSIS FACTOR BLOCKING AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY by Fiocco, U, Cantini, F, Matucci Cerinic, M, Ferri, C, Botsios, C, Intorcia, M, Bombardieri, S

Get full text